The airway delivery of genetic material inside the cell requires the design of vector nanoparticles (NPs) showing low cytotoxicity, high efficiency in cellular absorption and ability to penetrate the mucus barrier before releasing material to the nucleus. Polyamidoamines (PAAs) are promising condensing structures for DNA and siRNA delivery, since they show good biocompatibility, biodegradability and the ability to form stable polyplexes both with DNA and RNA strains. Among these we exploited the potential of the 4-aminobutylguanidine-deriving PAA named AGMA1 to transport siRNA and to target the enzyme β-glucocerebrosidase GBA2 from primary Human Bronchial Epithelial cells (hBEC) of patients affected by Cystic Fibrosis (CF). CF patients’ mucus is a strong viscoelastic barrier leading to respiratory disease and high infection risk. We’re testing lipid coating on AGMA1-siRNA complexes as a possible strategy to cross the CF mucus barrier. Transfection efficiency, cytotoxicity and siRNA efficacy have been investigated on primary cellular cultures (ALI hBEC cultures). Besides, the structural properties of the nanoparticles have been studied by Light Scattering experiments.

Bioinspired polymers for siRNA delivery by lipid based nanovectors / E. Traficante, E. DI COLA, E. DEL FAVERO, V.M. Rondelli, C. Laura, P. Brocca, F. Lazzari - In: What's going on in polymer science! Proceedings of the Milan polymer days congress MIPOL2018Ebook. - [s.l] : Edises, 2018 Feb 15. - ISBN 9788879598712. - pp. 88-88 (( Intervento presentato al 2. convegno Milan Polymer Days MIPOL tenutosi a Milano nel 2018.

Bioinspired polymers for siRNA delivery by lipid based nanovectors

Emanuela Di Cola;Elena Del Favero;Valeria Rondelli;Laura Cantù;Paola Brocca;Federica Lazzari
2018-02-15

Abstract

The airway delivery of genetic material inside the cell requires the design of vector nanoparticles (NPs) showing low cytotoxicity, high efficiency in cellular absorption and ability to penetrate the mucus barrier before releasing material to the nucleus. Polyamidoamines (PAAs) are promising condensing structures for DNA and siRNA delivery, since they show good biocompatibility, biodegradability and the ability to form stable polyplexes both with DNA and RNA strains. Among these we exploited the potential of the 4-aminobutylguanidine-deriving PAA named AGMA1 to transport siRNA and to target the enzyme β-glucocerebrosidase GBA2 from primary Human Bronchial Epithelial cells (hBEC) of patients affected by Cystic Fibrosis (CF). CF patients’ mucus is a strong viscoelastic barrier leading to respiratory disease and high infection risk. We’re testing lipid coating on AGMA1-siRNA complexes as a possible strategy to cross the CF mucus barrier. Transfection efficiency, cytotoxicity and siRNA efficacy have been investigated on primary cellular cultures (ALI hBEC cultures). Besides, the structural properties of the nanoparticles have been studied by Light Scattering experiments.
Settore CHIM/04 - Chimica Industriale
http://www.mipol.unimi.it/2018/Booklet_MIPOL2018.pdf
Book Part (author)
File in questo prodotto:
File Dimensione Formato  
Traficante_P36.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 82.93 kB
Formato Adobe PDF
82.93 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/557104
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact